Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Varenicline versus placebo for smoking cessation in adults with HIV infection
2008-007948-34Phase 3Active
- Sponsor
- ANRS
- Start
- Mar 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in nicotine dependence comparing Champix with Placebo (2 arms). Primary endpoint: Continuous smoking abstinence from week 9 to week 48. Started Mar 2009; status: active.
02
Drugs
varenicline
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on 2008-007948-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-007948-34.